FDA Clearance Tracker · P100044
PROPEL
Last checked: Nov 20, 2026Latest source record: Aug 11, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Aug 11, 2011
Approved
Time to decision
248 days
Received Dec 6, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P100044
- Device name
- PROPEL
- Applicant
- Intersect Ent.
- Applicant location
- Menlo Park, CA
- Received
- Dec 6, 2010
- Decided
- Aug 11, 2011
- Decision
- Approved
- Supplements
- 59 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Drug-eluting sinus stent (OWO)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PROPEL SINUS IMPLANT. THIS DEVICE IS INDICATED FOR USE IN PATIENTS >= 18 YEARS OF AGE FOLLOWING ETHMOID SINUS SURGERY TO MAINTAIN PATENCY, THEREBY REDUCING THE NEED FOR POST-OPERATIVE INTERVENTION SUCH AS SURGICAL ADHESION LYSIS AND/OR USE OF ORAL STEROIDS. THE PROPEL SINUS IMPLANT SEPARATES MUCOSAL TISSUES, PROVIDES STABILIZATION OF THE MIDDLE TURBINATE, PREVENTS OBSTRUCTION BY ADHESIONS, AND REDUCES EDEMA.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OWO (Drug-eluting sinus stent).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Intersect Ent.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VenSure LightGuide510(k)
K212774 · Decided Feb 4, 2022 · 156 days after receipt
Device type: Instrument, Ent Manual Surgical (LRC) · Otolaryngology (ENT)
- PROPEL CONTOUR SINUS IMPLANTPMA supplement
P100044-S023 · Decided Feb 23, 2017 · 206 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S018 · Decided Mar 23, 2016 · 180 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.